Country Manager
Veracyte
Country Manager
Veracyte
Genomic cancer diagnostics and non-invasive tests
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help patients make life-changing decisions.
Our Values:
This role supports regional market pricing strategies and drives commercial growth by educating oncologists and pathologists on the clinical and economic value of Veracyte’s diagnostic tests. It involves close collaboration with marketing to execute key initiatives, such as congresses and seminars, and includes people management responsibilities—guiding and developing regional team members across functions. The role ensures compliance with corporate policies, oversees regional performance, and manages administrative tasks efficiently.
This position supports the DACH region, with a strong preference for candidates based in Germany.
Key Responsibilities
Who You Are:
#LI-Remote
Veracyte is a growing company that offers significant career opportunities if you are curious, driven, patient-oriented and aspire to help us build a great company. We offer competitive compensation and benefits, and are committed to fostering an inclusive workforce, where diverse backgrounds are represented, engaged, and empowered to drive innovative ideas and decisions. We are thrilled to be recognized as a 2024 Certified™ Great Place to Work® in both the US and Israel - a testament to our dynamic, inclusive, and inspiring workplace where passion meets purpose.
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
Veracyte, Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability status. Veracyte participates in E-Verify in the United States. View our CCPA Disclosure Notice
If you receive any suspicious alerts or communications through LinkedIn or other online job sites for any position at Veracyte, please exercise caution and promptly report any concerns to [email protected]
COMPENSATION INPUT: Range To Be Posted: 117,817 - 140,753
Veracyte develops and sells genomic tests used to detect and diagnose cancer. Its tests are non-invasive when possible, using samples such as nasal swabs or tissue biopsies to analyze genetic information and help determine cancer risk or prognosis. One of its notable offerings is the Decipher Prostate genomic classifier, which estimates prostate cancer prognosis, alongside other tests for early lung cancer risk assessment. The company works with hospitals, clinics, and individual practitioners to provide tools that improve diagnostic accuracy and guide treatment decisions. Veracyte differentiates itself by focusing on clinically validated, non-invasive genomic assays that support early detection and personalized care, and by expanding its test portfolio through ongoing research and clinical studies. Its goal is to help healthcare providers achieve earlier, more accurate cancer diagnoses, improve patient outcomes, and use medical resources more efficiently.
Explore more opportunities at Veracyte